Andrew Jefferson

OverviewAI-generated summary

Andrew Jefferson leads a research group at the University of Arkansas for Medical Sciences, focusing on the development of accessible scientific instrumentation and the study of molecular mechanisms underlying cellular integrity. His work includes the creation of a 3D-printed automated XYZT fluorescence imaging system, designed for educational, outreach, and fieldwork applications, with publications detailing this system appearing in both 2021 and 2022. This project reflects an interest in making advanced scientific tools more widely available.

In parallel, Jefferson investigates the molecular underpinnings of neuronal health. His research has explored the role of the Cdk12 gene in maintaining axon integrity, specifically by regulating actin remodeling. Publications from 2022 and 2023 detail how Cdk12 contributes to the stability of the axon initial segment and the overall health of adult axons. He has also contributed to studies on clinical practices, including a 2025 publication analyzing epinephrine prescription and post-injection monitoring for biologic therapies in pediatric severe asthma clinics.

Jefferson's scholarship metrics include an h-index of 25, with 69 total publications and over 2,133 citations. He is recognized as a highly cited researcher. His key collaborators at the University of Arkansas for Medical Sciences include Erhan Ararat and Robert D. Pesek, with whom he shares publications.

Metrics

• h-index: 24
• Publications: 64
• Citations: 2,117